Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy

Withdrawn before enrolling · Phase 4

Conditions studied: Atopic Dermatitis

In brief

This study is designed to determine whether the addition of topical Altabax (R) to a treatment regimen of topical corticosteroid therapy speeds clearance of atopic dermatitis and improves quality of life.

Key facts

Study ID
NCT00871208
Run by
St. Luke's-Roosevelt Hospital Center
People needed
0
Starts
2009-05-01
Expected to finish
2010-05-01
Last updated by the study team
2015-05-12

Who can join

Age: 1 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.